Evidence map›Paper›PMID 42582341›Full record

ArticleClinical case reports2026

Structural Restoration of an Unruptured Vertebral Artery Dissection Following Autologous Mesenchymal Stem Cell Therapy: A Case Report.

Hyungchang Kang, Eung Jae Lee, Moon Hyoung Lee, Hyun Soo Kim

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hyungchang KangDr. Kim's Stem Cell Clinic Seoul Republic of Korea.ORCID https://orcid.org/0009-0008-3429-2853
Eung Jae LeeGreenhospital Seoul Republic of Korea.
Moon Hyoung LeeDr. Kim's Stem Cell Clinic Seoul Republic of Korea.ORCID https://orcid.org/0000-0002-7268-0741
Hyun Soo KimR&D Center Pharmicell Co. Ltd. Seongnam Republic of Korea.ORCID https://orcid.org/0009-0007-5186-3868

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vertebral artery dissection (VAD) is a recognized cause of ischemic stroke, and current management relies on antithrombotic therapy that is not specifically directed at structural repair of the arterial wall. We report a man in his mid-50s who presented with a sudden, severe right occipital headache after a golf swing and had a history of a contralateral left VAD 16 years earlier. High-resolution vessel wall magnetic resonance imaging and angiography showed an acute, unruptured dissection of the right V4 segment with an intramural hematoma, and serial imaging documented progression of the true-lumen stenosis before treatment. Because the lesion was progressing and stenting of the intracranial V4 segment carried a high risk of iatrogenic rupture, autologous bone marrow-derived mesenchymal stem cells (MSCs) were administered as a well-tolerated adjunct to continued antithrombotic therapy, in two systemic infusions at 8 weeks and 10 months after onset. The patient had an uneventful clinical course with no infusion-related adverse events, and follow-up imaging at 11 months showed resorption of the intramural hematoma and restoration of a normal-appearing lumen and wall. Because spontaneous healing of unruptured VAD cannot be excluded, this single, uncontrolled observation cannot establish that MSC therapy caused the recovery; nonetheless, the treatment was well-tolerated and the favorable course warrants evaluation in adequately controlled studies before any therapeutic role of MSCs in VAD can be defined.

Indexed as

autologous mesenchymal stem cellscase reportvascular remodelingvertebral artery dissectionvessel wall MRI

Identifiers

PMID42582341
PMCPMC13457658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.